Stock Market Today, Feb. 18: Kenvue Rises After Earnings Beat Expectations

Kenvue (NYSE:KVUE), maker of consumer health products including Tylenol, Neutrogena, and Listerine, closed Wednesday at $18.88, up 2.55%. The stock moved higher after Q4 results beat expectations and analysts raised price targets, while investors are watching progress on the pending Kimberly-Clark (NASDAQ:KMB) acquisition and related restructuring plans.Trading volume reached 46.9 million shares, coming in roughly 3.9% above its three-month average of 45.2 million shares. Kenvue IPO'd in 2023 and has fallen ...